drugset / Trial / NCT03423355
Dapagliflozin Effect on Erythropoiesis and Physical Fitness
RandomizedParallel-groupTriple-blindTreatment
Summary
Dapagliflozin effect on erythropoiesis and physical fitness in patients with type 2 diabetes - a randomized, partly double-blinded, controlled, three armed, parallel group, exploratory study
Timeline
- Start
- 2021-09
- Primary completion
- 2023-03
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | Oral |